SHUTTLE PHARMACEUTICALS

shuttle-pharmaceuticals-logo

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. While there are several therapies being developed with the goal of curing cancer, one of the most effective and proven approaches to this is radiation therapy (RT).

#SimilarOrganizations #People #Website #More

SHUTTLE PHARMACEUTICALS

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2012-01-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.shuttlepharma.com

Total Employee:
11+

Status:
Active

Contact:
240-403-4212

Email Addresses:
[email protected]

Total Funding:
912.5 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Google Cloud Sectigo SSL Sectigo Domain SSL


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.


Current Advisors List

j-martin-brown_image

J. Martin Brown Scientific Advisor @ Shuttle Pharmaceuticals
Advisor

ralph-weichselbaum_image

Ralph Weichselbaum Scientific Advisor @ Shuttle Pharmaceuticals
Advisor

eliot-rosen_image

Eliot Rosen Scientific Advisor @ Shuttle Pharmaceuticals
Advisor

Current Employees Featured

anatoly-dritschilo_image

Anatoly Dritschilo
Anatoly Dritschilo CEO & Co-Founder @ Shuttle Pharmaceuticals
CEO & Co-Founder

peter-dritschilo_image

Peter Dritschilo
Peter Dritschilo CFO @ Shuttle Pharmaceuticals
CFO

mira-jung_image

Mira Jung
Mira Jung CRB @ Shuttle Pharmaceuticals
CRB

theodore-l-phillips_image

Theodore L Phillips
Theodore L Phillips CMO @ Shuttle Pharmaceuticals
CMO

milton-brown_image

Milton Brown,
Milton Brown, CSO @ Shuttle Pharmaceuticals
CSO

Founder


anatoly-dritschilo_image

Anatoly Dritschilo

Stock Details


Company's stock symbol is NASDAQ:SHPH

Official Site Inspections

http://www.shuttlepharma.com Semrush global rank: 6.06 M Semrush visits lastest month: 1.34 K

  • Host name: 151.101.130.159
  • IP address: 151.101.130.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Shuttle Pharmaceuticals"

About us | Shuttle Pharmaceuticals

The Company was originally founded as Shuttle Pharmaceuticals, LLC in December 2012 in the State of Maryland. In June 2018, Shuttle Pharmaceuticals, Inc. became a wholly owned …See details»

Management Team | Shuttle Pharmaceuticals

Contact us. Shuttle Pharmaceuticals 401 Professional Drive Suite 260 Gaithersburg, MD 20879See details»

Shuttle Pharmaceuticals - Crunchbase Company Profile …

Organization. Shuttle Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 240-403-4212; Shuttle …See details»

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) - Yahoo Finance

See the company profile for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) including business summary, industry/sector information, number of employees, business summary, corporate …See details»

Shuttle Pharmaceuticals

Dec 12, 2024 Since 1995, Shuttle Pharma has been providing high-quality, innovative products and services to healthcare institutions, consumers and business partners around the world.See details»

Shuttle Pharmaceuticals, Inc. | LinkedIn

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapies and diagnostics to improve the outcomes for cancer patients treated with radiation therapy.See details»

Shuttle Pharma - Company Profile - Tracxn

Sep 16, 2024 Shuttle Pharma - Developing therapies to improve outcome of radiation therapy in cancer suffering patients. Public Company. Raised a total funding of $1.03M over 3 rounds. …See details»

Shuttle Pharma Enters into Sponsored Research Agreement

Dec 19, 2024 [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email protected] ...See details»

Contact us - shuttlepharma.com

Oct 30, 2024 GAITHERSBURG, Md., Oct. 29, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage …See details»

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with

Jan 8, 2024 Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., [email protected] Investor Contacts Lytham Partners, LLC Robert Blum 602-889 …See details»

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) - Stock Analysis

Jan 3, 2025 About SHPH. Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops …See details»

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of

Oct 30, 2024 GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a …See details»

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase …

GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage …See details»

Shuttle Pharmaceuticals Holdings Inc. - Cruelty Free Investing

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat …See details»

Shuttle Pharmaceuticals Provides Fiscal Year 2022 Corporate Update

Dec 31, 2022 Engaged Theradex Oncology, a leading clinical research organization, to help prepare for its upcoming clinical study of Ropidoxuridine. Entered into an agreement to lease …See details»

Shuttle Pharmaceuticals CEO Anatoly Dritschilo to Speak at

2 days ago [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email protected]. This article was originally published on Quiver News, …See details»

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor ...

2 days ago GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and …See details»

Royalty Pharma simplifies corporate structure with $1.1 bln deal

40 minutes ago Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to …See details»

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor ...

3 days ago GAITHERSBURG, Md., Jan. 07, 2025 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty …See details»

Press Releases | Shuttle Pharmaceuticals

Contact us. Shuttle Pharmaceuticals 401 Professional Drive Suite 260 Gaithersburg, MD 20879See details»

linkstock.net © 2022. All rights reserved